BAUSCH AND LOMB Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BAUSCH AND LOMB, and what generic alternatives to BAUSCH AND LOMB drugs are available?
BAUSCH AND LOMB has eighty-three approved drugs.
There are forty-nine US patents protecting BAUSCH AND LOMB drugs.
There are four hundred and seventy-four patent family members on BAUSCH AND LOMB drugs in forty-seven countries and eighty supplementary protection certificates in fifteen countries.
Summary for BAUSCH AND LOMB
International Patents: | 474 |
US Patents: | 49 |
Tradenames: | 76 |
Ingredients: | 58 |
NDAs: | 83 |
Drugs and US Patents for BAUSCH AND LOMB
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch And Lomb Inc | XIIDRA | lifitegrast | SOLUTION/DROPS;OPHTHALMIC | 208073-001 | Jul 11, 2016 | AB | RX | Yes | Yes | 9,085,553 | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Bausch And Lomb | TIMOLOL MALEATE | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 074776-001 | Mar 25, 1997 | AT1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Bausch And Lomb | ZIRGAN | ganciclovir | GEL;OPHTHALMIC | 022211-001 | Sep 15, 2009 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Bausch And Lomb | PENTOLAIR | cyclopentolate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 040075-001 | Apr 29, 1994 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Bausch And Lomb Inc | XIIDRA | lifitegrast | SOLUTION/DROPS;OPHTHALMIC | 208073-001 | Jul 11, 2016 | AB | RX | Yes | Yes | 8,084,047 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |
Bausch And Lomb | DEXASPORIN | dexamethasone; neomycin sulfate; polymyxin b sulfate | SUSPENSION/DROPS;OPHTHALMIC | 064135-001 | Sep 13, 1995 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BAUSCH AND LOMB
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch And Lomb | PROLENSA | bromfenac sodium | SOLUTION/DROPS;OPHTHALMIC | 203168-001 | Apr 5, 2013 | 9,561,277 | ⤷ Sign Up |
Bausch And Lomb | ISTALOL | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 021516-001 | Jun 4, 2004 | 6,335,335 | ⤷ Sign Up |
Bausch And Lomb | LOTEMAX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020583-001 | Mar 9, 1998 | 5,540,930*PED | ⤷ Sign Up |
Bausch And Lomb | ISTALOL | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 021516-001 | Jun 4, 2004 | 6,645,963 | ⤷ Sign Up |
Bausch And Lomb | LOTEMAX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020583-001 | Mar 9, 1998 | 5,747,061*PED | ⤷ Sign Up |
Bausch And Lomb Inc | XIBROM | bromfenac sodium | SOLUTION/DROPS;OPHTHALMIC | 021664-001 | Mar 24, 2005 | 4,910,225 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for BAUSCH AND LOMB drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Ophthalmic Solution | 0.07% | ➤ Subscribe | 2013-07-26 |
➤ Subscribe | Ophthalmic Solution | 0.5% | ➤ Subscribe | 2012-10-19 |
➤ Subscribe | Ophthalmic Solution | 1.5% | ➤ Subscribe | 2013-09-09 |
International Patents for BAUSCH AND LOMB Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2013010778 | ⤷ Sign Up |
European Patent Office | 3488847 | ⤷ Sign Up |
Taiwan | I468394 | ⤷ Sign Up |
Spain | 2787039 | ⤷ Sign Up |
Japan | 2011516607 | ⤷ Sign Up |
Hungary | S1100022 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for BAUSCH AND LOMB Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1631293 | 2014C/042 | Belgium | ⤷ Sign Up | PRODUCT NAME: MIRVASO (BRIMONIDINE) EN FARMACEUTISCHE ZOUTEN DAARVAN VOOR GEBRUIK ALS MEDICIJN VOOR HET BEHANDELEN VAN ROSACEA GEINDUCEERDE ROODHEID; AUTHORISATION NUMBER AND DATE: EU/1/13/904 20140221 |
0957929 | PA2006004 | Lithuania | ⤷ Sign Up | PRODUCT NAME: PEGAPTANIBUM; REG. NO/DATE: EU/1/05/325/001 20060131 |
1429780 | 13C0012 | France | ⤷ Sign Up | PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808 |
3461484 | 21C1024 | France | ⤷ Sign Up | PRODUCT NAME: ASSOCIATION DE NETARSUDIL OU L'UN DE SES SELS ET DE LATANOPROST; REGISTRATION NO/DATE: EU/1/20/1502 20210108 |
0799044 | 02C0040 | France | ⤷ Sign Up | PRODUCT NAME: OLOPATADINE HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/02/217/001 20020517 |
1586316 | 132011901975261 | Italy | ⤷ Sign Up | PRODUCT NAME: BROMFENAC(YELLOX); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/11/692/001, 20110518 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.